GtreeBNT files IND with Korean regulatory for phase IIB/III trial of RGN-259 to treat dry eye syndrome
Date
2014-12-31
G-treeBNT files IND with Korean regulatory for phase IIB/III trial of RGN-259 to treat dry eye syndrome
(if you want to view the body of article, click on the bottom link)
http://www.pharmabiz.com/NewsDetails.aspx?aid=85924&sid=2
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S. - 2015.01.28 날자로 등록
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S.
(if you want to view the body of article, click on the bottom link)
http://www.prnewswire.com/news-releases/regenerx-and-g-treebnt-create-joint-venture-to-develop-rgn-259-in-the-us-300027130.html
(if you want to view the body of article, click on the bottom link)
http://www.pharmabiz.com/NewsDetails.aspx?aid=85924&sid=2
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S. - 2015.01.28 날자로 등록
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S.
(if you want to view the body of article, click on the bottom link)
http://www.prnewswire.com/news-releases/regenerx-and-g-treebnt-create-joint-venture-to-develop-rgn-259-in-the-us-300027130.html